financetom
HMN
financetom
/
Financials
/
HMN
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Horace Mann Educators CorporationHMN
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Horace Mann Educators Corporation, together with its subsidiaries, operates as an insurance holding company in the United States.

The company operates through Property & Casualty, Life & Retirement, and Supplemental & Group Benefits segments.

Its Property & Casualty segment offers insurance products, including private passenger auto insurance and residential home insurance; and provides auto coverages including liability and collision, and property coverage for homeowners and renters.

The Life & Retirement segment markets tax-qualified fixed, fixed indexed, and variable annuities; and internal revenue code for educator, which allows public school employees and employees of other tax-exempt organizations, such as not-for-profit private schools, to utilize pretax income to make periodic contributions to a qualified retirement plan.

Supplemental & Group Benefits segment offers employer-sponsored products including accident, critical illness, limited-benefit fixed indemnity insurance, term life, and short-term and long-term disability, as well as worksite direct products, such as supplemental heart, cancer, disability, and accident coverage.

The company was founded in 1945 and is headquartered in Springfield, Illinois.

Latest News >
Boeing on track to be 2024's biggest loser in Dow Jones Index
Boeing on track to be 2024's biggest loser in Dow Jones Index
Dec 31, 2024
(Reuters) - U.S. planemaker Boeing ( BA ) is on track to be the biggest loser of 2024 in the Dow Jones Index, tumbling 32% as it bounced from one crisis to another.  Rival Airbus rose more than 11% for the year, and the benchmark S&P 500 gained more than 23% during 2024.  Boeing's ( BA ) shares opened the...
Ultragenyx Pharmaceutical Insider Sold Shares Worth $495,231, According to a Recent SEC Filing
Ultragenyx Pharmaceutical Insider Sold Shares Worth $495,231, According to a Recent SEC Filing
Dec 31, 2024
02:11 PM EST, 12/31/2024 (MT Newswires) -- Emil D Kakkis, Director, President & CEO, on December 30, 2024, sold 11,727 shares in Ultragenyx Pharmaceutical ( RARE ) for $495,231. Following the Form 4 filing with the SEC, Kakkis has control over a total of 2,748,590 shares of the company, with 564,605 shares held directly and 2,183,985 controlled indirectly. SEC Filing:...
Legacy Housing Insider Sold Shares Worth $425,099, According to a Recent SEC Filing
Legacy Housing Insider Sold Shares Worth $425,099, According to a Recent SEC Filing
Dec 31, 2024
02:11 PM EST, 12/31/2024 (MT Newswires) -- Curtis Drew Hodgson, 10% Owner, Director, on December 30, 2024, sold 17,300 shares in Legacy Housing ( LEGH ) for $425,099. Following the Form 4 filing with the SEC, Hodgson has control over a total of 4,173,778 shares of the company, with 404,722 shares held directly and 3,769,056 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1436208/000110465924132810/xslF345X05/tm2432358-1_4seq1.xml...
Update: ADC Shares Rise After Company Completes Enrollment in Late-Stage Zynlonta Combination Trial
Update: ADC Shares Rise After Company Completes Enrollment in Late-Stage Zynlonta Combination Trial
Dec 31, 2024
02:15 PM EST, 12/31/2024 (MT Newswires) -- (Updates with stock price movement in the headline and first paragraph) ADC Therapeutics ( ADCT ) gained as much as 4.2% in intraday trading Tuesday after the company said it had completed patient enrollment in its phase 3 confirmatory trial of Zynlonta in combination with rituximab in patients with relapsed or refractory diffuse...
Copyright 2023-2025 - www.financetom.com All Rights Reserved